Osteoprotegerin (OPG)
[Edit]TNFRSF11B; TNFRSF11-B; OCIF; OPG; TR1; Tumor Necrosis Factor Receptor Superfamily Member 11b; Osteoclastogenesis Inhibitory Factor
-90108.jpg)
Osteoprotegerin (OPG) is a cytokine, which can inhibit the production of osteoclasts. It is a member of the tumor necrosis factor (TNF) receptor superfamily. It is a basic glycoprotein comprising 401 amino acid residues arranged into 7 structural domains. It is found as either a 60 kDa monomer or 120 kDa dimer linked by disulfide bonds.Osteoprotegerin inhibits the differentiation of osteoclast precursors into osteoclasts and also regulates the resorption of osteoclasts in vitro and in vivo. Osteoprotegerin is a RANK homolog, and works by binding to RANKL on osteoblast/stromal cells, thus blocking the RANKL-RANK ligand interaction between osteoblast/stromal cells and osteoclast precursors. This has the effect of inhibiting the differentiation of the osteoclast precursor into a mature osteoclast.
Organism species: Homo sapiens (Human)
| CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
| Proteins | RPA108Hu01 | Recombinant Osteoprotegerin (OPG) | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPA108Hu61 | Eukaryotic Osteoprotegerin (OPG) | Positive Control; Immunogen; SDS-PAGE; WB. | |
| APA108Hu01 | Active Osteoprotegerin (OPG) | Cell culture; Activity Assays. | |
| RPA108Hu02 | Recombinant Osteoprotegerin (OPG) | Positive Control; Immunogen; SDS-PAGE; WB. | |
| APA108Hu61 | Active Osteoprotegerin (OPG) | Cell culture; Activity Assays. | |
| Antibodies | PAA108Hu01 | Polyclonal Antibody to Osteoprotegerin (OPG) | WB; IHC; ICC; IP. |
| MAA108Hu22 | Monoclonal Antibody to Osteoprotegerin (OPG) | WB; IHC; ICC; IP. | |
| PAA108Hu06 | Polyclonal Antibody to Osteoprotegerin (OPG) | WB; IHC; ICC; IP. | |
| MAA108Hu21 | Monoclonal Antibody to Osteoprotegerin (OPG) | WB; IHC; ICC; IP. | |
| MAA108Hu23 | Monoclonal Antibody to Osteoprotegerin (OPG) | WB; IHC; ICC; IP. | |
| Assay Kits | SEA108Hu | ELISA Kit for Osteoprotegerin (OPG) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCA108Hu | CLIA Kit for Osteoprotegerin (OPG) | Chemiluminescent immunoassay for Antigen Detection. |
Organism species: Mus musculus (Mouse)
| CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
| Proteins | RPA108Mu01 | Recombinant Osteoprotegerin (OPG) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA108Mu02 | Recombinant Osteoprotegerin (OPG) | Positive Control; Immunogen; SDS-PAGE; WB. | |
| EPA108Mu61 | Eukaryotic Osteoprotegerin (OPG) | Positive Control; Immunogen; SDS-PAGE; WB. | |
| Antibodies | PAA108Mu01 | Polyclonal Antibody to Osteoprotegerin (OPG) | WB; IHC; ICC; IP. |
| PAA108Mu02 | Polyclonal Antibody to Osteoprotegerin (OPG) | WB; IHC; ICC; IP. | |
| Assay Kits | SEA108Mu | ELISA Kit for Osteoprotegerin (OPG) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCA108Mu | CLIA Kit for Osteoprotegerin (OPG) | Chemiluminescent immunoassay for Antigen Detection. |
Organism species: Rattus norvegicus (Rat)
| CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
| Proteins | RPA108Ra01 | Recombinant Osteoprotegerin (OPG) | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPA108Ra61 | Eukaryotic Osteoprotegerin (OPG) | Positive Control; Immunogen; SDS-PAGE; WB. | |
| EPA108Ra62 | Eukaryotic Osteoprotegerin (OPG) | Positive Control; Immunogen; SDS-PAGE; WB. | |
| Antibodies | PAA108Ra01 | Polyclonal Antibody to Osteoprotegerin (OPG) | WB; IHC; ICC; IP. |
| MAA108Ra21 | Monoclonal Antibody to Osteoprotegerin (OPG) | WB; IHC; ICC; IP. | |
| Assay Kits | SEA108Ra | ELISA Kit for Osteoprotegerin (OPG) | Enzyme-linked immunosorbent assay for Antigen Detection. |
Organism species: Canis familiaris; Canine (Dog)
| CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
| Proteins | n/a | Recombinant Osteoprotegerin (OPG) | Recombinant Protein Customized Service Offer |
| Antibodies | n/a | Monoclonal Antibody to Osteoprotegerin (OPG) | Monoclonal Antibody Customized Service Offer |
| n/a | Polyclonal Antibody to Osteoprotegerin (OPG) | Polyclonal Antibody Customized Service Offer | |
| Assay Kits | SEA108Ca | ELISA Kit for Osteoprotegerin (OPG) | Enzyme-linked immunosorbent assay for Antigen Detection. |
Organism species: Sus scrofa; Porcine (Pig)
| CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
| Proteins | RPA108Po01 | Recombinant Osteoprotegerin (OPG) | Positive Control; Immunogen; SDS-PAGE; WB. |
| Antibodies | PAA108Po01 | Polyclonal Antibody to Osteoprotegerin (OPG) | WB; IHC; ICC; IP. |
| MAA108Po21 | Monoclonal Antibody to Osteoprotegerin (OPG) | WB; IHC; ICC; IP. | |
| Assay Kits | SEA108Po | ELISA Kit for Osteoprotegerin (OPG) | Enzyme-linked immunosorbent assay for Antigen Detection. |
Organism species: Capra hircus; Caprine (Goat)
| CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
| Proteins | RPA108Cp01 | Recombinant Osteoprotegerin (OPG) | Positive Control; Immunogen; SDS-PAGE; WB. |
| Antibodies | PAA108Cp01 | Polyclonal Antibody to Osteoprotegerin (OPG) | WB; IHC; ICC; IP. |
| Assay Kits | n/a | CLIA Kit for Osteoprotegerin (OPG) | CLIA Kit Customized Service Offer |
| n/a | ELISA Kit for Osteoprotegerin (OPG) | ELISA Kit Customized Service Offer |
Organism species: Chicken (Gallus)
| CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
| Proteins | RPA108Ga01 | Recombinant Osteoprotegerin (OPG) | Positive Control; Immunogen; SDS-PAGE; WB. |
| Antibodies | PAA108Ga01 | Polyclonal Antibody to Osteoprotegerin (OPG) | WB; IHC; ICC; IP. |
| MAA108Ga01 | Monoclonal Antibody to Osteoprotegerin (OPG) | WB; IHC; ICC; IP. | |
| Assay Kits | SEA108Ga | ELISA Kit for Osteoprotegerin (OPG) | Enzyme-linked immunosorbent assay for Antigen Detection. |
- "Osteoprotegerin: a novel secreted protein involved in the regulation of bone density." Cell 89:309-319(1997) [PubMed] [Europe PMC] [Abstract]
- "Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro."Endocrinology 139:1329-1337(1998) [PubMed] [Europe PMC] [Abstract]
- "Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor."Eur. J. Biochem. 254:685-691(1998) [PubMed] [Europe PMC] [Abstract]
- "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
- "DNA sequence and analysis of human chromosome 8." Nature 439:331-335(2006) [PubMed] [Europe PMC] [Abstract]
- "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
- "Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor."Biochem. Biophys. Res. Commun. 245:382-387(1998) [PubMed] [Europe PMC] [Abstract]
- "Signal peptide prediction based on analysis of experimentally verified cleavage sites."Protein Sci. 13:2819-2824(2004) [PubMed] [Europe PMC] [Abstract]
- "Cloning and expression of a novel mutated osteoprogerin/osteoclastogenesis inhibitory factor gene."Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 31:680-684(1999) [PubMed] [Europe PMC] [Abstract]
- "Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis."Biochem. Biophys. Res. Commun. 234:137-142(1997) [PubMed] [Europe PMC] [Abstract]
- "Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL."J. Biol. Chem. 273:14363-14367(1998) [PubMed] [Europe PMC] [Abstract]
- "Characterization of structural domains of human osteoclastogenesis inhibitory factor."J. Biol. Chem. 273:5117-5123(1998) [PubMed] [Europe PMC] [Abstract]
- "Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases."Cancer 92:460-470(2001) [PubMed] [Europe PMC] [Abstract]
- "Crystal structure of human RANKL complexed with its decoy receptor osteoprotegerin."J. Immunol. 189:245-252(2012) [PubMed] [Europe PMC] [Abstract]
- "A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype."Hum. Mol. Genet. 11:2119-2127(2002) [PubMed] [Europe PMC] [Abstract]